Markets:

Overview

News

Currencies

International

Treasuries

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

27.31 +0.37 (+1.37%)

Streaming Delayed Price Updated: 12:25 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ACADIA Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

October 10, 2023

JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 02, 2023

Via Benzinga

2 Growth Stocks I'd Buy on the Dip ↗

September 30, 2023

These two growth stocks could be worthwhile buy-and-holds.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 28, 2023

Via Benzinga

Analyst Ratings for ACADIA Pharmaceuticals ↗

August 22, 2023

Via Benzinga

Can This Red-Hot Biotech Stock Keep Beating the Broader Markets? ↗

August 22, 2023

This biotech stock has been on fire in 2023.

Via The Motley Fool

Analyst Expectations for ACADIA Pharmaceuticals's Future ↗

August 03, 2023

Via Benzinga

ACADIA Pharmaceuticals's Earnings: A Preview ↗

August 01, 2023

Via Benzinga

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 22, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Why Acadia Pharmaceuticals Stock Is Soaring Today ↗

July 14, 2023

Investors are cheering Acadia's latest news.

Via The Motley Fool

Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications

September 19, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

August 30, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

2 Supercharged Growth Stocks Billionaires Can't Stop Buying ↗

August 28, 2023

A top hedge fund has been steadily buying these two growth stocks in 2023.

Via The Motley Fool

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street ↗

August 16, 2023

This small-cap biotech might be a hidden gem.

Via The Motley Fool

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 14, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know ↗

August 07, 2023

Via Benzinga

Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview

August 02, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer

July 24, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023

July 19, 2023

From Acadia Pharmaceuticals Inc.

Via Business Wire

Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves

July 18, 2023

Acadia may experience a profit-taking pullback near-term but the recent high volume gapper and promising pipeline developments bode well for long-term uptrend.

Via MarketBeat

Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views ↗

July 14, 2023

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Friday. The Dow traded up 0.30% to 34,498.91 while the NASDAQ fell 0.36% to 14,087. The S&P...

Via Benzinga

Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets ↗

July 14, 2023

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American

Via Benzinga

Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 14, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.

Via Benzinga

Crude Oil Down 2%; Citigroup Profit Tops Estimates ↗

July 14, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Friday. The Dow traded up 0.31% to 34,501.62 while the NASDAQ rose 0.36% to 14,188.86. The S&P 500, also...

Via Benzinga

Acadia's Newest Drug Just Obliterated Sales Expectations; Shares Hit Two-Year High ↗

July 14, 2023

The company also expanded its commercial rights to the drug and added another to its line-up.

Via Investor's Business Daily

UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday ↗

July 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Are Acadia Pharmaceuticals Shares Trading Higher Today? ↗

July 14, 2023

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher after the company expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American

Via Benzinga

Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 14, 2023

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.